# Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies

**Authors:** Zakir Khan, Yusuf Karatas, Ahmet Akici, Maria Auxiliadora Parreiras Martins, Nafees Ahmad

PMC · DOI: 10.3389/fphar.2024.1473052 · Frontiers in Pharmacology · 2024-08-20

## Full-text entities

- **Genes:** IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}
- **Diseases:** type II hypersensitivity (MESH:D006969), breast cancer (MESH:D001943), atrial fibrillation (MESH:D001281), thrombocytopenia (MESH:D013921), oral paraesthesia (MESH:D020820), vomiting (MESH:D014839), cardiac arrhythmias (MESH:D001145), COVID-19 (MESH:D000086382), Raynaud's phenomenon (MESH:D011928), overdose (MESH:D062787), stroke (MESH:D020521), hypertension (MESH:D006973), immune system disorders (MESH:D007154), throat tightness (MESH:C538390), weight gain (MESH:D015430), menstruation disorders (MESH:D008599), AS (MESH:D013167), neurocognitive impairment (MESH:D019965), pericarditis (MESH:D010493), loss of consciousness (MESH:D014474), acute lung injury (MESH:D055371), pulmonary oedema (MESH:D011654), ADRs (MESH:D064420)
- **Chemicals:** eptinezumab (MESH:C000628361), atomoxetine (MESH:D000069445), dupilumab (MESH:C582203), heparin (MESH:D006493), sacituzumab govitecan (MESH:C000608132), galcanezumab (MESH:C000628360), erenumab (MESH:C000605816), bDMARDs (-), methylphenidate (MESH:D008774), fremanezumab (MESH:C000604315), molnupiravir (MESH:C000656703), low-molecular-weight heparin (MESH:D006495), mepolizumab (MESH:C434107), oxaliplatin (MESH:D000077150), amphetamine (MESH:D000661)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11368867/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC11368867/full.md

---
Source: https://tomesphere.com/paper/PMC11368867